Filing Details

Accession Number:
0001209191-15-079484
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-11-12 07:37:15
Reporting Period:
2015-11-11
Filing Date:
2015-11-12
Accepted Time:
2015-11-12 07:37:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1593034 Endo International Plc ENDP Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1034273 Michael Hyatt 745 Fifth Avenue
New York NY 10151
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2015-11-11 10,000 $31.43 259,599 No 4 M Direct
Ordinary Shares Disposition 2015-11-11 8,000 $55.48 251,599 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares 2004 Stock Incentive Plan Stock Options (NQ) Disposition 2015-11-11 10,000 $0.00 10,000 $31.43
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2016-03-13 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Ordinary Shares 10,375 Indirect In Trust
Footnotes
  1. This represents the average price per share of ordinary shares that Mr. Hyatt sold on the open market on November 11, 2015 at prices ranging from $55.36 to $55.64.
  2. This number represents ordinary shares indirectly held by Mr. Hyatt. These ordinary shares are held in trusts for which Mr. Hyatt serves as trustee and holds either sole or shared power of disposition and vote.
  3. Mr. Hyatt's stock options that were granted under the 2004 Stock Incentive Plan on March 13, 2006 were generally exercisable 25% per year on March 13, 2007, March 13, 2008, March 13, 2009, and March 13, 2010.
  4. These securities were granted to Mr. Hyatt in 2006 in consideration of his services on the Endo Health Solutions Inc. Board of Directors.